PolyPeptide Group AG

Direct answer

PolyPeptide Group AG is publicly traded on SIX under the ticker PPGN.SW.

PolyPeptide Group AG operates globally as a contract development and manufacturing organization (CDMO), specializing in the production of Good Manufacturing Practice (GMP)-grade peptides. These peptides, available in both proprietary and generic forms, are vital for pharmaceutical and biotechnology companies, serving as key ingredients in approved medicines, compounds undergoing clinical development, and generic...

Can you invest in PolyPeptide Group AG?

Yes. PolyPeptide Group AG is publicly traded on SIX under the ticker PPGN.SW.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for PolyPeptide Group AG

Detailed equity research is provided by MarketSnap.